skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Deep dive into China’s clinical landscape to learn more about the startling growth in clinical research in our whitepaper from Dr Annie Siu, PhD, MBA, APAC - Content Director, Informa Pharma Intelligence and Andrew Benson, MSc - Senior Director, Trialtrove.


China Clinical Trials Landscape

Uncover the latest trends and analysis for clinical trials in the largest growing market in the Pharma industry including:

  • Has China caught up to the giants of the pharma industry on the global stage
  • China’s trial initiations from 2016 to 2020
  • The Top industry sponsors of China trials
  • Clinical trials by therapeutic area
  • The future after COVID-19

Download the China Clinical Trials Landscape to uncover all the key insights.

China Clinical Trials Landscape

Clinical Trials Round-up

Here is a teaser of what to expect from our annual Clinical Trials Round-up insight

  • Year-over-year growth rate of 26% in clinical trials, a sharp contrast from the prior year
  • A promising start to 2021, with nearly half of 2020 trial activity – see what’s driving this
  • What is the most active therapeutic area? Infectious disease certainly caused an explosion of trial activity
  • AstraZeneca reclaims its crown as the most active company, unseating last year’s leader, Bristol-Myers Squibb
  • Just how many trials aimed to treat and/or prevent COVID-19?
Clinical Trials Round-up

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: